NCT06521931 2026-03-02
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1 Completed
Clinical Trials
20 trialsNCT03471078 2023-09-28
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Sobi, Inc.
Phase 3 Completed
NCT04631211 2023-05-25
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Cellphire Therapeutics, Inc.
Phase 2 Terminated
NCT01957176 2022-12-30
A Rollover Study to Provide Continued Treatment With Eltrombopag
Novartis
Phase 4 Completed
NCT02964325 2021-08-19
MIPLATE
Terumo BCTbio
Phase NA Terminated
NCT01773187 2020-09-29
Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
CTI BioPharma
Phase 3 Terminated
NCT01663441 2020-09-16
A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11
Beijing Northland Biotech. Co., Ltd.
Phase 3 Completed
NCT01890746 2019-09-11
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
Novartis
Phase 2 Completed
NCT02389621 2018-10-30
L-PLUS 2
Shionogi Inc.
Phase 3 Completed
NCT03567798 2018-06-27
papayaleaf
Socrates School Of Health
Phase NA Completed
NCT00358540 2017-11-13
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
GlaxoSmithKline
Phase 1 Completed
NCT01440374 2017-06-05
ASPIRE
Novartis
Phase 2 Completed
NCT00102726 2017-03-23
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
GlaxoSmithKline
Phase 2 Completed
NCT01444417 2017-02-09
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Amgen
Phase 3 Completed
NCT01147809 2016-04-18
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
GlaxoSmithKline
Phase 2 Completed
NCT01345214 2014-04-01
A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Ono Pharmaceutical Co. Ltd
Phase 1 Terminated
NCT00413283 2013-10-24
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Amgen
Phase 2 Completed
NCT00283439 2011-06-20
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
Amgen
Phase 1/2 Completed
NCT00039910 2007-05-04
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Pfizer
Phase 3 Completed
NCT00037791 2006-11-09
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Pfizer
Phase 3 Completed